228 related articles for article (PubMed ID: 31511488)
1. Importance of a Liver Biopsy in the Management of Wilson Disease.
Oe S; Honma Y; Yabuki K; Morino K; Kumamoto K; Hayashi T; Kusanaga M; Ogino N; Minami S; Shibata M; Abe S; Harada M
Intern Med; 2020 Jan; 59(1):77-81. PubMed ID: 31511488
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
[TBL] [Abstract][Full Text] [Related]
3. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
[No Abstract] [Full Text] [Related]
4. Wilson Disease: Diagnosis, Treatment, and Follow-up.
Schilsky ML
Clin Liver Dis; 2017 Nov; 21(4):755-767. PubMed ID: 28987261
[TBL] [Abstract][Full Text] [Related]
5. Wilson disease: histopathological correlations with treatment on follow-up liver biopsies.
Cope-Yokoyama S; Finegold MJ; Sturniolo GC; Kim K; Mescoli C; Rugge M; Medici V
World J Gastroenterol; 2010 Mar; 16(12):1487-94. PubMed ID: 20333789
[TBL] [Abstract][Full Text] [Related]
6. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
7. Wilson's disease: overview.
Lucena-Valera A; Ruz-Zafra P; Ampuero J
Med Clin (Barc); 2023 Mar; 160(6):261-267. PubMed ID: 36697289
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of Wilson disease in Japan].
Shimizu N
Rinsho Shinkeigaku; 2019 Sep; 59(9):565-569. PubMed ID: 31474637
[TBL] [Abstract][Full Text] [Related]
9. A copper for your thoughts.
Coates RA
J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415
[No Abstract] [Full Text] [Related]
10. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C
Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731
[TBL] [Abstract][Full Text] [Related]
11. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
[TBL] [Abstract][Full Text] [Related]
12. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of Wilson disease].
Smolarek C; Stremmel W
Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
[TBL] [Abstract][Full Text] [Related]
14. Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction.
Harada M; Miyagawa K; Honma Y; Hiura M; Shibata M; Matsuhashi T; Abe S; Harada R; Tabaru A
Intern Med; 2011; 50(14):1461-4. PubMed ID: 21757830
[TBL] [Abstract][Full Text] [Related]
15. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
[TBL] [Abstract][Full Text] [Related]
16. Wilson disease in children: analysis of 57 cases.
Manolaki N; Nikolopoulou G; Daikos GL; Panagiotakaki E; Tzetis M; Roma E; Kanavakis E; Syriopoulou VP
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):72-7. PubMed ID: 19172127
[TBL] [Abstract][Full Text] [Related]
17. Manifestations and evolution of Wilson disease in pediatric patients carrying ATP7B mutation L708P.
Peña-Quintana L; García-Luzardo MR; García-Villarreal L; Arias-Santos MD; Garay-Sánchez P; Santana A; González-Santana D; Ramos-Varela JC; Rial-González R; Tugores A
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):48-54. PubMed ID: 21832955
[TBL] [Abstract][Full Text] [Related]
18. [Wilson's disease and its pharmacological treatment].
Hayashi H; Suzuki R; Wakusawa S
Yakugaku Zasshi; 2004 Nov; 124(11):711-24. PubMed ID: 15516801
[TBL] [Abstract][Full Text] [Related]
19. Wilson's disease and copper metabolism--a review.
Manghani DK; Dastur DK
Indian J Gastroenterol; 1985 Apr; 4(2):91-3. PubMed ID: 3886537
[No Abstract] [Full Text] [Related]
20. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
Falkmer S; Samuelson G; Sjölin S
Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
[No Abstract] [Full Text] [Related]
[Next] [New Search]